Veeva Summit Highlights AI Push to Streamline Drug Development and…

Event summary

Veeva Systems will host its R&D and Quality Summit on October 20-21, 2026, in Boston, with over 2,500 attendees expected.
The event will showcase AI innovations, including Veeva Falcon agentic labor and Vault AI agentic platform.
Key participants include Eli Lilly, Pfizer, Sanofi, and UCB, discussing AI integration in drug development and quality operations.
New capabilities in Veeva Development Cloud and Veeva Quality Cloud applications will be highlighted.
Pfizer is piloting cloud LIMS to speed global medicine delivery and set the path for AI.

The big picture

Veeva's summit underscores the growing importance of AI in streamlining drug development and quality operations, a trend that is reshaping the biopharmaceutical industry. With over 1,500 customers, Veeva is positioning itself as a key player in the digital transformation of life sciences, leveraging its industry cloud to drive efficiency and innovation. The event highlights the strategic shift towards automation and connected trials, which are critical for reducing costs and accelerating time-to-market for new therapies.

What we're watching

AI Adoption: How Veeva's AI innovations will accelerate drug development and quality operations across its customer base.
Industry Collaboration: Whether the partnerships with Eli Lilly, Pfizer, and others will drive significant advancements in clinical trials and manufacturing.
Market Differentiation: The pace at which Veeva can sustain its leadership position in the life sciences cloud market amid increasing competition.